Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment

Shu Ning(University of California, Davis), Allen C. Gao(UC Davis Comprehensive Cancer Center)

Molecular Cancer Therapeutics

August 5, 2022

10.1158/1535-7163.mct-22-0216

Cited by 21

Related Papers

IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer

|iScience|2024|11

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

|Communications Medicine|2022|10